These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1277205

  • 21. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A, Iwata T, Yamaguchi K, Shiratori O, Harada M.
    Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
    [Abstract] [Full Text] [Related]

  • 22. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK, Waxman DJ.
    Cancer Res; 1993 Jun 01; 53(11):2490-7. PubMed ID: 8495410
    [Abstract] [Full Text] [Related]

  • 23. Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.
    Draeger J, Peter G, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr 01; 60(4):355-9. PubMed ID: 1277211
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug 01; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract] [Full Text] [Related]

  • 25. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry.
    Przybylski M, Ringsdorf H, Voelcker G, Draeger U, Peter G, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr 01; 60(4):509-16. PubMed ID: 1277228
    [Abstract] [Full Text] [Related]

  • 26. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H, Jacob-Müller U.
    Teratology; 1981 Feb 01; 23(1):7-13. PubMed ID: 7245091
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC, Ramonas LM, Zaharko DS, Kohn KW.
    Cancer Res; 1980 Nov 01; 40(11):4216-20. PubMed ID: 7471062
    [Abstract] [Full Text] [Related]

  • 28. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I, Bakopoulou A, Papageorgiou A, Iakovidou Z, Mioglou E, Nikolaropoulos S, Mourelatos D, Lialiaris T.
    Mutat Res; 2009 Apr 30; 675(1-2):51-9. PubMed ID: 19386248
    [Abstract] [Full Text] [Related]

  • 29. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V, Martino R, Malet-Martino M, Niemeyer U, Pohl J.
    J Med Chem; 1999 Jul 15; 42(14):2542-60. PubMed ID: 10411475
    [Abstract] [Full Text] [Related]

  • 30. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
    Draeger U, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr 15; 60(4):423-7. PubMed ID: 1277217
    [Abstract] [Full Text] [Related]

  • 31. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May 15; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 32. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
    Fleer R, Brendel M.
    Chem Biol Interact; 1982 Mar 01; 39(1):1-15. PubMed ID: 7037214
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
    Kutscher B, Niemeyer U, Engel J, Kleemann A, Hilgard P, Pohl J, Scheffler G.
    Arzneimittelforschung; 1995 Mar 01; 45(3):323-6. PubMed ID: 7741794
    [Abstract] [Full Text] [Related]

  • 34. Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect.
    Donelli MG, Bartosek I, Guaitani A, Martini A, Colombo T, Pacciarini MA, Modica R.
    Cancer Treat Rep; 1976 Apr 01; 60(4):395-401. PubMed ID: 1277213
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF.
    Cancer Res; 1982 Aug 01; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract] [Full Text] [Related]

  • 36. [Immunosuppressive effect of various cytostatics on humoral antibody formation].
    Potel J, Brock N.
    Arzneimittelforschung; 1971 Aug 01; 21(8):1250-4. PubMed ID: 5110029
    [No Abstract] [Full Text] [Related]

  • 37. Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.
    Takamizawa A, Matsumoto S, Iwata T, Tochino Y, Katagiri K, Yamaguchi K.
    J Med Chem; 1975 Apr 01; 18(4):376-83. PubMed ID: 1121004
    [Abstract] [Full Text] [Related]

  • 38. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ, Bansal SK, Paul B, Koser PL, Love J, Struck RF, Gurtoo HL.
    Cancer Res; 1984 Oct 01; 44(10):4615-21. PubMed ID: 6380709
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT, White KL.
    Cancer Res; 1988 Jan 01; 48(1):41-5. PubMed ID: 3257162
    [Abstract] [Full Text] [Related]

  • 40. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
    Niculescu-Duvăz I, Feyns V, Dobre V.
    Cancer Treat Rep; 1978 Dec 01; 62(12):2045-54. PubMed ID: 751714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.